Earlier measles vaccine could help curb global outbreak

Earlier measles vaccine

Earlier measles vaccine could help curb global outbreak according to systematic review: The global measles outbreak must trigger an urgent debate into whether a vaccine should be recommended earlier to better protect against the highly contagious disease during infancy, a new review states. The systematic review, led by Murdoch Children’s Research Institute (MCRI), found vaccinating […]

Read More… from Earlier measles vaccine could help curb global outbreak

Antibodies Found to Shield Against Secondary Heart Attack Damage

Secondary

Heart attack: antibodies identified to protect against secondary damage. New research is shedding light on the hidden mechanisms behind heart attacks and offering hope for more effective treatments. A recent study by MedUni Vienna has uncovered previously unknown cellular processes that occur in the blocked coronary arteries leading to heart attacks. In a study led […]

Read More… from Antibodies Found to Shield Against Secondary Heart Attack Damage

Further illnesses still expected from SARS-CoV-2

SARS-CoV-2

SARS-CoV-2: Only neutralising antibodies allow conclusions to be drawn about protection against new infections: Mutations of virus and illnesses caused by new variants are still to be expected even in a SARS-CoV-2 situation that has now become endemic. Although the population has developed specific immune responses due to previous infections and vaccinations, vaccinated and vulnerable individuals […]

Read More… from Further illnesses still expected from SARS-CoV-2

Memory killer T cells at lower frequency

killer T cells

Memory killer cells at lower frequency: Unvaccinated children mount COVID-19 immune response, but vaccination may be key to strengthening immunity: Unvaccinated children mount a rapid immune response to SARS-CoV-2 which may contribute to less severe symptoms, but which may also limit the development of an immune “memory” response to ward off future infections, a study […]

Read More… from Memory killer T cells at lower frequency

Cancer Treatment influences vaccine response

vaccine

The type of cancer treatment influences vaccine response: Cancer patients are at increased risk of SARS-CoV-2 infection and severe COVID-19 courses. Coronavirus vaccination is generally recommended for cancer patients, but so far little is known about how well they respond to the vaccine. In a study now published in the high-ranking journal JAMA Oncology (Impact […]

Read More… from Cancer Treatment influences vaccine response

Covid-19: herd immunity in Sweden fails to materialise

cow grazing

Sweden’s policy of allowing the controlled spread of Covid-19 viral infection among the population has so far failed to deliver the country’s previously stated goal of herd immunity. Commenting on recent antibody testing clinical and research findings, authors of a paper published by the Journal of the Royal Society of Medicine, write that Sweden’s higher rates of viral infection, hospitalisation and mortality compared with neighbouring […]

Read More… from Covid-19: herd immunity in Sweden fails to materialise

Covid-19: Not all patients develop protective antibodies

antibodies

A laboratory test that has now been developed by a study group from MedUni Vienna is able to determine whether COVID-19 patients develop protective antibodies after having the disease. The main finding of the test is as follows: the scientists from MedUni Vienna’s Institute of Pathophysiology and Allergy Research discovered that only around 60% of […]

Read More… from Covid-19: Not all patients develop protective antibodies

Engineered antibodies from llamas neutralise COVID-19 virus

llamas

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today. Llamas, produce a special type of antibody, far smaller than the size of a typical human antibody (one quarter of the size). These“single-domain” antibodies, or nanobodies, have several features that make them of interest as potential […]

Read More… from Engineered antibodies from llamas neutralise COVID-19 virus

Covid-19: WHO brief on Immunity passports

A Scientific Brief on “Immunity passports” in the context of COVID-19 has been published by the World Health Organisation. WHO has published guidance on adjusting public health and social measures for the next phase of the COVID-19 response.(1) Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, […]

Read More… from Covid-19: WHO brief on Immunity passports